Mode
Text Size
Log in / Sign up
N/A Completed N=14 Randomized Treatment

Electrical Stimulation in Diabetic Peripheral Neuropathy

NMES · Control
Source: ClinicalTrials.gov NCT02082145 ↗
Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Oct 2019
Primary outcomePrimary: Nerve Conduction Speed (Common Peroneal Nerve) — 33.93; 44.1; 41.63; 44.13 m/sec

Summary

To assess the effect of the device on the progression of diabetic peripheral neuropathy

Outcome Measures

OutcomeResultp-value
PRIMARY
Nerve Conduction Speed (Common Peroneal Nerve)
33.93; 44.1; 41.63; 44.13
SECONDARY
PAID - Quality of Life Questionnaires
26.2; 27.4; 40.29; 5

Eligibility Criteria

Inclusion criteria

  • 18+ years old
  • Diabetes as defined by WHO diagnostic criteria on best medical therapy
  • Diabetic peripheral polyneuropathy present, confirmed by nerve conduction testing

Exclusion criteria

  • Pregnancy
  • Pacemaker
  • Metal implants in the legs (below knee)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02082145). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search